BioPharma Trends in the News – June 2025
Source: Fierce Biotech The FDA is implementing an AI tool named Elsa to expedite drug application reviews, aiming to process initial submissions, sometimes exceeding 500,000 pages and analyzing it in a matter of minutes. Challenges remain as Elsa sometimes produces inaccurate or unreliable responses so all AI-generated outputs will still

Rules of Engagement for the Tools of Engagement
Discover proven strategies for selecting the right engagement tools for pharmaceutical Virtual Speaker Programs to create memorable peer-to-peer learning experiences that drive results.

Why Your Field Should Be Using Virtual Speaker Programs
Field representatives often (mistakenly) perceive that virtual speaker programs are not worth the effort. We hear some clients saying that their representatives resist virtual programs because they claim they’re too difficult to set up. They take too much time. Technology is a hurdle. These perceptions have become one of the

Vision2Voice Joins PAO Action Week™ to Support Patient Advocacy
Vision2Voice (V2V) is proud to participate in Patient Advocacy Organization (PAO) Action Week™ from June 9–13. Founded by Astellas Pharma Inc., PAO Action Week celebrates the vital work of Patient Advocacy Organizations—more than 1,200 U.S. nonprofits that amplify the voices, needs, and rights of patients, particularly those living with serious

Top 5 Myths About National Broadcasts — and the Truth Behind Them
National broadcasts have an excellent impact on investment in education, as measured by both market share change and return on investment, but there are still many myths to overcome. Let’s shed light on the most common myths we encounter and share what the reality looks like for companies that have successfully

What’s Trending in the News – April 2025
Source: PharmaVoice The tariff war has prompted new calls to reshore manufacturing. Several large organizations have already made the leap as BioPharma leverages technological advances such as continuous manufacturing, AI-enabled processes, robotics and automation have brought labor costs down, and regulators are offering more support. READ FULL ARTICLE Source: Reuters

Common Pitfalls and Solutions When Planning Advisory Boards
Pharmaceutical advisory boards are vital opportunities to gather expert input, but their success depends greatly on planning and facilitation. Too often, companies treat key opinion leaders (KOLs) like celebrities rather than partners, stifling honest feedback and diverse perspectives. The real value emerges when facilitators create an environment where all participants

KOL/KEE Identification: 3 Common Strategies – Dan Recommends
When an existing client or new client calls me about key opinion leader (KOL) or Key External Expert (KEE) Identification, they have a purpose in mind for conducting this research. These are some of my favorite client discussions because they are usually with strategic individuals looking to solve internal challenges.